MIT engineers developed an implantable reservoir that can remain under the skin and be triggered to release glucagon when people with diabetes are in danger of becoming hypoglycemic.
Thats encouraging to hear. Six months without rejection or encystment is good. Human trials are going to require a longer period though but the new membrane technology is looking promising. Hope this reaches patients rapidly if it works out
Thats encouraging to hear. Six months without rejection or encystment is good. Human trials are going to require a longer period though but the new membrane technology is looking promising. Hope this reaches patients rapidly if it works out
https://clinicaltrials.gov/search?cond=Diabetes+Mellitus+Type+1&intr=Islet+transplant